Seeking Alpha

Regeneron Pharmaceuticals (REGN): Q1 EPS of $0.37 may not be comparable to consensus of by...

Regeneron Pharmaceuticals (REGN): Q1 EPS of $0.37 may not be comparable to consensus of by -$0.33. Revenue of $232M (+106% Y/Y). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|